You are here

CAMRAS VISION, INC.

Company Information
Address
2 Davis Drive
RTP, NC 27709-0003
United States


http://www.camrasvision.com

Information

UEI: CLLKJRDMUC49

# of Employees: 5


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Safety and Efficacy of a Titratable External Shunt

    Amount: $886,057.00

    Glaucoma is a diverse group of chronic diseases that causes irreversible damage to the optic nerve and is a leading cause of blindness affectingmillion people worldwideIt is estimated thatinpeople who ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  2. SBIR Phase II: Adjustable Eye Pressure Control within an External Shunt

    Amount: $713,172.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project allows for a more effective glaucoma treatment by adjusting eye pressure based on disease pro ...

    SBIRPhase II2016National Science Foundation
  3. Safety and Efficacy of a Titratable External Shunt

    Amount: $299,981.00

    Glaucoma is a diverse group of chronic diseases that causes irreversible damage to the optic nerve and is a leading cause of blindness affecting million people worldwide It is estimated that in people ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  4. SBIR Phase I:Feasibility of Adjustable Eye Pressure Control within an External Shunt

    Amount: $150,000.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project allows for a more effective glaucoma treatment by tailoring eye pressure based on disease prog ...

    SBIRPhase I2015National Science Foundation
  5. SBIR Phase I: Feasibility of The Use of a Debris Cartridge in an External Drainage Device

    Amount: $149,978.00

    This Small Business Innovation Research Phase I project will demonstrate the feasibility of the use of a debris cartridge in an implant to prevent obstruction in debris-releasing glaucomas, such as uv ...

    SBIRPhase I2013National Science Foundation
  6. External Glaucoma Drainage Device

    Amount: $176,270.00

    DESCRIPTION (provided by applicant): Glaucoma is one of the leading causes of blindness in the world affecting 67 million people. Reduction of intraocular pressure (IOP) is the only proven treatment f ...

    STTRPhase I2012Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government